Welcome to our dedicated page for Bio-Key Intl news (Ticker: BKYI), a resource for investors and traders seeking the latest updates and insights on Bio-Key Intl stock.
BIO-key International, Inc. (NASDAQ: BKYI) is an identity and access management (IAM) and biometric authentication company whose news flow centers on product innovation, strategic partnerships, investor communications, and capital markets activity. Press releases describe BIO-key as a biometric-centric, multi-factor IAM provider enabling phoneless, tokenless, passwordless, and phishing-resistant authentication for enterprise and large-scale identity deployments.
On this page, readers can follow updates on BIO-key’s participation in industry conferences and investor events, such as the Gartner Identity & Access Management Summit, the Africa Tech Festival, and the DealFlow Discovery investor conference. These announcements often highlight new passwordless capabilities, identity-bound biometric technologies, and demonstrations of the PortalGuard IAM platform.
Company news also covers strategic partnerships that extend BIO-key’s reach in key regions. Recent releases describe collaborations with SAVIS Group in Vietnam, VaporVM in the Middle East and Africa, and Cloud Distribution in Saudi Arabia. Through these relationships, BIO-key’s IAM and biometric solutions are integrated into broader cybersecurity and digital transformation offerings for enterprises, government agencies, and institutions.
Investors can track earnings-related communications and balance sheet updates through quarterly results announcements and associated investor calls. BIO-key’s news includes details on hardware launches such as the EcoID III fingerprint scanner, as well as disclosures about warrant exercise agreements and secured promissory notes that affect the company’s capital structure.
By monitoring the BKYI news feed, users can see how BIO-key positions its biometric and IAM technologies in sectors such as defense, finance, government, and education, and stay informed about material events reported in press releases that complement the company’s formal SEC filings.
BIO-key (NASDAQ: BKYI) announced a strategic partnership with TD SYNNEX Public Sector (DLT) on March 12, 2026 to deliver identity-bound biometric and IAM solutions to U.S. federal, state, and local agencies. The collaboration integrates PortalGuard and Passkey:YOU into DLT contract vehicles to simplify procurement and support Zero Trust, phishing-resistant MFA, and compliance with CJIS, HIPAA, and NIST SP 800-171.
Key capabilities include NIST-tested, FBI-certified fingerprint biometrics, centralized SSO/IDaaS via PortalGuard, multi-factor authentication across 20+ methods, and self-service tools to reduce help-desk costs.
BIO-key (NASDAQ: BKYI) reported a new $280,000 order from a foreign defense ministry, bringing that customer's bookings to $1.14M in the past 12 months and BIO-key's total military/defense orders to over $2M in the last year.
The company highlights demand for phoneless, tokenless biometric authentication for SCIF and FME environments, support for more than 50,000 licensed users at the customer, and certifications including NIST, FBI FAP and FIPS 201.
BIO-key (NASDAQ: BKYI) secured a $1.04M one-year license renewal and expansion from a foreign retail bank on March 3, 2026, a 30% increase versus prior year. The company reports $2.7M year-end cash and expects receivables and renewals to fund growth internally. Deployment has grown from 7M enrolled clients in 2015 to over 30M today (≈300M fingerprints); the renewal anticipates 5% client enrollment growth and notes ~10,000 bank employees use the fingerprint system.
BIO-key (NASDAQ: BKYI) announced a multi-year agreement with Sociedade Interbancária de Moçambique (SIMO) on Feb. 24, 2026 to modernize identity and access security across Mozambique’s national payments network.
Integration will deploy PortalGuard IAM, PIN:You tokenless authentication and SSO via partner RunLevel, building on a May 2025 pilot and marking BIO-key’s 11th banking customer globally.
BIO-key (NASDAQ: BKYI) announced a planned Mumbai office launch and a strategic value‑added distributor partnership with Citadel Global to expand its India presence, led by BIO-key EMEA, dated Jan 29, 2026. The initiative targets large enterprises, financial institutions, and call centers and aligns with the EU–India free trade agreement to accelerate biometric IAM adoption. Citadel will provide pre-sales, deployment, training, and customer success support while BIO-key’s portfolio (PortalGuard, Passkey:YOU, Identity‑Bound Biometrics, WEB-key) will be delivered via Citadel’s local infrastructure.
BIO-key (NASDAQ: BKYI) formed a strategic partnership with Visualforma to deploy IAM and biometric authentication across Portugal’s public sector. Visualforma will lead a nationwide rollout covering more than 250 government organizations, with operational deployments already active in municipal, educational, healthcare, and a major tourist-city environment.
The program uses PortalGuard, PIN:You, WEB-key, Identity-Bound Biometrics, and certified scanners to enhance cybersecurity, regulatory compliance, and citizen-facing digital services while aligning with Cartão de Cidadão and eIDAS frameworks.
BIO-key (NASDAQ:BKYI) will present at the DealFlow Discovery investor conference at the Borgata in Atlantic City on Jan. 28–29, 2026. CEO Mike DePasquale is scheduled to present on Jan. 28 at 11:30am ET in Room 1 and will be available for 1-on-1 investor meetings during the event. Institutional investors, family offices, and high-net-worth investors may register at no cost. Presentation materials will be posted on the DealFlow Discovery website in January and registration is available online.
BIO-key (NASDAQ: BKYI) will present at the DealFlow Discovery investor conference on Jan 28–29, 2026 at the Borgata hotel in Atlantic City, New Jersey.
CEO Mike DePasquale will deliver a presentation and be available for 1-on-1 meetings; presentation details will be posted on the conference website in January. Institutional investors, family offices and high-net-worth investors may register to attend at no cost via the DealFlow Discovery registration page.
BIO-key (NASDAQ: BKYI) will participate in the 2025 Gartner Identity & Access Management Summit: North America, December 8-10 in Grapevine, TX, exhibiting at Booth 236. The company will demonstrate its passwordless, phoneless, tokenless authentication portfolio including identity-bound biometrics, phishing-resistant MFA alternatives, and cost-effective IAM modernization aimed at reducing credential theft, support costs, and friction while supporting Zero Trust adoption.
BIO-key will engage IAM leaders across finance, healthcare, government, education, and manufacturing to discuss deployment use cases and challenges.
BIO-key (NASDAQ: BKYI) announced a strategic partnership with SAVIS Group to localize and deliver BIO-key’s identity and biometric authentication solutions across Vietnam, effective Nov 17, 2025. SAVIS Group will act as an authorized distributor, providing localized pre-sales, deployment, and technical support through its enterprise ecosystem.
Products to be offered include PortalGuard, Passkey:YOU (FIDO2), PIN:You, WEB-key, identity-bound biometrics, and certified scanners PIV-Pro and EcoID III.